U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Myopic astigmatism

MedGen UID:
748561
Concept ID:
C2363771
Disease or Syndrome
Synonyms: Astigmatism, Myopic; Myopic Astigmatism; Myopic Astigmatisms
SNOMED CT: Myopic astigmatism (449724005)
 
HPO: HP:0500041

Definition

A condition where one or both of the two principal meridians focus in the front of the retina when the eye is at rest. [from HPO]

Term Hierarchy

Conditions with this feature

Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability
MedGen UID:
320559
Concept ID:
C1835265
Disease or Syndrome
Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development (MCLMR) is an autosomal dominant disorder that involves an overlapping but variable spectrum of central nervous system and ocular developmental anomalies. Microcephaly ranges from mild to severe and is often associated with mild to moderate developmental delay and a characteristic facial phenotype with upslanting palpebral fissures, broad nose with rounded tip, long philtrum with thin upper lip, prominent chin, and prominent ears. Chorioretinopathy is the most common eye abnormality, but retinal folds, microphthalmia, and myopic and hypermetropic astigmatism have also been reported, and some individuals have no overt ocular phenotype. Congenital lymphedema, when present, is typically confined to the dorsa of the feet, and lymphoscintigraphy reveals the absence of radioactive isotope uptake from the webspaces between the toes (summary by Ostergaard et al., 2012). Robitaille et al. (2014) found that MCLMR includes a broader spectrum of ocular disease, including retinal detachment with avascularity of the peripheral retina, and noted phenotypic overlap with familial exudative vitreoretinopathy (FEVR; see EVR1, 133780). Birtel et al. (2017) observed intrafamilial and intraindividual variability in retinal phenotype, and noted that syndromic manifestations in some patients are too subtle to be detected during a routine ophthalmologic evaluation. Variable expressivity and reduced penetrance have also been observed in some families (Jones et al., 2014; Li et al., 2016). Autosomal recessive forms of microcephaly with chorioretinopathy have been reported (see 251270). See also Mirhosseini-Holmes-Walton syndrome (autosomal recessive microcephaly with pigmentary retinopathy and impaired intellectual development; 268050), which has been mapped to chromosome 8q21.3-q22.1.
Achromatopsia 2
MedGen UID:
387867
Concept ID:
C1857618
Disease or Syndrome
Achromatopsia is characterized by reduced visual acuity, pendular nystagmus, increased sensitivity to light (photophobia), a small central scotoma, eccentric fixation, and reduced or complete loss of color discrimination. All individuals with achromatopsia (achromats) have impaired color discrimination along all three axes of color vision corresponding to the three cone classes: the protan or long-wavelength-sensitive cone axis (red), the deutan or middle-wavelength-sensitive cone axis (green), and the tritan or short-wavelength-sensitive cone axis (blue). Most individuals have complete achromatopsia, with total lack of function of all three types of cones. Rarely, individuals have incomplete achromatopsia, in which one or more cone types may be partially functioning. The manifestations are similar to those of individuals with complete achromatopsia, but generally less severe. Hyperopia is common in achromatopsia. Nystagmus develops during the first few weeks after birth followed by increased sensitivity to bright light. Best visual acuity varies with severity of the disease; it is 20/200 or less in complete achromatopsia and may be as high as 20/80 in incomplete achromatopsia. Visual acuity is usually stable over time; both nystagmus and sensitivity to bright light may improve slightly. Although the fundus is usually normal, macular changes (which may show early signs of progression) and vessel narrowing may be present in some affected individuals. Defects in the macula are visible on optical coherence tomography.
Hermansky-Pudlak syndrome 8
MedGen UID:
854728
Concept ID:
C3888026
Disease or Syndrome
Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.
Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy
MedGen UID:
1615361
Concept ID:
C4540493
Disease or Syndrome
Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy (NDMSCA) is an autosomal recessive disorder characterized by severe global developmental delay with poor motor and intellectual function apparent soon after birth, as well as postnatal progressive microcephaly. Most patients develop early-onset, frequent, and often intractable seizures, compatible with an epileptic encephalopathy. Other features include poor feeding, poor overall growth, absent speech, poor or absent eye contact, inability to achieve walking, hypotonia, and peripheral spasticity. Brain imaging usually shows progressive cerebral atrophy, thin corpus callosum, and abnormalities in myelination. Death in childhood may occur (summary by Siekierska et al., 2019).
Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA
MedGen UID:
1675664
Concept ID:
C5193102
Disease or Syndrome
Neurodevelopmental disorder with or without variable brain abnormalities (NEDBA) is characterized by global developmental delay apparent from infancy or early childhood, resulting in mildly delayed walking, variably impaired intellectual development, and poor or absent speech. Additional features may include hypotonia, spasticity, or ataxia. About half of patients have abnormal findings on brain imaging, including cerebral or cerebellar atrophy, loss of white matter volume, thin corpus callosum, and perisylvian polymicrogyria. Seizures are not a prominent finding, and although some patients may have nonspecific dysmorphic facial features, there is no common or consistent gestalt (summary by Platzer et al., 2019).
Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies
MedGen UID:
1794140
Concept ID:
C5561930
Disease or Syndrome
X-linked syndromic intellectual developmental disorder with pigmentary mosaicism and coarse facies (MRXSPF) is characterized by a phenotypic triad of severe developmental delay, coarse facial dysmorphisms, and Blaschkoid pigmentary mosaicism. Additional clinical features may include epilepsy, orthopedic abnormalities, hypotonia, and growth abnormalities. The disorder affects both males and females (Villegas et al., 2019; Diaz et al., 2020).
Developmental delay, language impairment, and ocular abnormalities
MedGen UID:
1824035
Concept ID:
C5774262
Disease or Syndrome
Developmental delay, language impairment, and ocular abnormalities (DEVLO) is characterized by delayed acquisition of skills particularly affecting speech and language development, although many patients show mild motor delay. Most affected individuals also have a small head circumference (down to -3 SD) and may have mild dysmorphic features. Variable ocular anomalies include strabismus, cataracts, and cortical visual impairment. Older patients require special schooling and often demonstrate behavioral abnormalities (Laboy Cintron et al., 2022).

Professional guidelines

PubMed

Biscevic A, Bohac M, Koncarevic M, Anticic M, Dekaris I, Patel S
Graefes Arch Clin Exp Ophthalmol 2015 Dec;253(12):2325-33. Epub 2015 Sep 24 doi: 10.1007/s00417-015-3177-x. PMID: 26400154
Al-Tobaigy FM
Middle East Afr J Ophthalmol 2012 Jul-Sep;19(3):304-8. doi: 10.4103/0974-9233.97931. PMID: 22837624Free PMC Article
Cherry PM
Ophthalmic Surg Lasers 1996 May;27(5 Suppl):S493-8. PMID: 8724158

Recent clinical studies

Etiology

Reinstein DZ, Archer TJ, Potter JG, Gupta R, Wiltfang R
J Refract Surg 2023 May;39(5):294-301. Epub 2023 May 1 doi: 10.3928/1081597X-20230301-02. PMID: 37162399
Moshirfar M, Webster CR, Ronquillo YC
Curr Opin Ophthalmol 2022 Sep 1;33(5):453-463. Epub 2022 Jun 27 doi: 10.1097/ICU.0000000000000870. PMID: 35916572
Tajbakhsh Z, Talebnejad MR, Khalili MR, Masoumpour MS, Mahdaviazad H, Mohammadi E, Keshtkar M, Nowroozzadeh MH
Clin Exp Optom 2022 Nov;105(8):860-864. Epub 2022 Jan 4 doi: 10.1080/08164622.2021.2003687. PMID: 34982953
Cañones-Zafra R, Katsanos A, Garcia-Gonzalez M, Gros-Otero J, Teus MA
Int Ophthalmol 2022 Jan;42(1):73-80. Epub 2021 Aug 9 doi: 10.1007/s10792-021-02001-x. PMID: 34370173
Řeháková T, Veliká V, Jirásková N
Cesk Slov Oftalmol 2019 Summer;75(2):65-71. doi: 10.31348/2019/2/2. PMID: 31537074

Diagnosis

Reinstein DZ, Archer TJ, Potter JG, Gupta R, Wiltfang R
J Refract Surg 2023 May;39(5):294-301. Epub 2023 May 1 doi: 10.3928/1081597X-20230301-02. PMID: 37162399
Sigireddi RR, Weikert MP
Curr Opin Ophthalmol 2020 Jan;31(1):10-14. doi: 10.1097/ICU.0000000000000627. PMID: 31770161
Blum M, Kunert KS, Schulze M, Sekundo W
J Refract Surg 2019 Nov 1;35(11):707-711. doi: 10.3928/1081597X-20191002-01. PMID: 31710372
Chow SSW, Chow LLW, Lee CZ, Chan TCY
Asia Pac J Ophthalmol (Phila) 2019 Sep-Oct;8(5):391-396. doi: 10.1097/01.APO.0000580140.74826.f5. PMID: 31490198Free PMC Article
Ganesh S, Brar S, Arra RR
Indian J Ophthalmol 2018 Jan;66(1):10-19. doi: 10.4103/ijo.IJO_761_17. PMID: 29283117Free PMC Article

Therapy

Reinstein DZ, Archer TJ, Potter JG, Gupta R, Wiltfang R
J Refract Surg 2023 May;39(5):294-301. Epub 2023 May 1 doi: 10.3928/1081597X-20230301-02. PMID: 37162399
Moshirfar M, Webster CR, Ronquillo YC
Curr Opin Ophthalmol 2022 Sep 1;33(5):453-463. Epub 2022 Jun 27 doi: 10.1097/ICU.0000000000000870. PMID: 35916572
Cañones-Zafra R, Katsanos A, Garcia-Gonzalez M, Gros-Otero J, Teus MA
Int Ophthalmol 2022 Jan;42(1):73-80. Epub 2021 Aug 9 doi: 10.1007/s10792-021-02001-x. PMID: 34370173
Mimouni M, Pokroy R, Rabina G, Kaiserman I
Int Ophthalmol 2021 Jun;41(6):2091-2098. Epub 2021 Mar 22 doi: 10.1007/s10792-021-01766-5. PMID: 33751303
Chow SSW, Chow LLW, Lee CZ, Chan TCY
Asia Pac J Ophthalmol (Phila) 2019 Sep-Oct;8(5):391-396. doi: 10.1097/01.APO.0000580140.74826.f5. PMID: 31490198Free PMC Article

Prognosis

Moshirfar M, Webster CR, Ronquillo YC
Curr Opin Ophthalmol 2022 Sep 1;33(5):453-463. Epub 2022 Jun 27 doi: 10.1097/ICU.0000000000000870. PMID: 35916572
Fawad A, Humayun S, Ishaq M, Arzoo S, Mashhadi SF, Humayun Q
J Coll Physicians Surg Pak 2022 Mar;32(3):329-334. doi: 10.29271/jcpsp.2022.03.329. PMID: 35148585
Blum M, Kunert KS, Schulze M, Sekundo W
J Refract Surg 2019 Nov 1;35(11):707-711. doi: 10.3928/1081597X-20191002-01. PMID: 31710372
Řeháková T, Veliká V, Jirásková N
Cesk Slov Oftalmol 2019 Summer;75(2):65-71. doi: 10.31348/2019/2/2. PMID: 31537074
Wang Y, Ma J
Asia Pac J Ophthalmol (Phila) 2019 Sep-Oct;8(5):412-416. doi: 10.1097/01.APO.0000580128.27272.bb. PMID: 31490200Free PMC Article

Clinical prediction guides

Yao L, Zhang M, Wang D, Zhao Q, Wang S, Bai H
Semin Ophthalmol 2023 Apr;38(3):283-293. Epub 2022 Jul 31 doi: 10.1080/08820538.2022.2107399. PMID: 35912896
Fawad A, Humayun S, Ishaq M, Arzoo S, Mashhadi SF, Humayun Q
J Coll Physicians Surg Pak 2022 Mar;32(3):329-334. doi: 10.29271/jcpsp.2022.03.329. PMID: 35148585
Cañones-Zafra R, Katsanos A, Garcia-Gonzalez M, Gros-Otero J, Teus MA
Int Ophthalmol 2022 Jan;42(1):73-80. Epub 2021 Aug 9 doi: 10.1007/s10792-021-02001-x. PMID: 34370173
Řeháková T, Veliká V, Jirásková N
Cesk Slov Oftalmol 2019 Summer;75(2):65-71. doi: 10.31348/2019/2/2. PMID: 31537074
Wang Y, Ma J
Asia Pac J Ophthalmol (Phila) 2019 Sep-Oct;8(5):412-416. doi: 10.1097/01.APO.0000580128.27272.bb. PMID: 31490200Free PMC Article

Recent systematic reviews

Yao L, Zhang M, Wang D, Zhao Q, Wang S, Bai H
Semin Ophthalmol 2023 Apr;38(3):283-293. Epub 2022 Jul 31 doi: 10.1080/08820538.2022.2107399. PMID: 35912896
Goes S, Delbeke H
J Cataract Refract Surg 2022 Oct 1;48(10):1204-1210. doi: 10.1097/j.jcrs.0000000000001007. PMID: 36179351
Kuryan J, Cheema A, Chuck RS
Cochrane Database Syst Rev 2017 Feb 15;2(2):CD011080. doi: 10.1002/14651858.CD011080.pub2. PMID: 28197998Free PMC Article
Barsam A, Allan BD
Cochrane Database Syst Rev 2014 Jun 17;2014(6):CD007679. doi: 10.1002/14651858.CD007679.pub4. PMID: 24937100Free PMC Article
Barsam A, Allan BD
Cochrane Database Syst Rev 2012 Jan 18;1:CD007679. doi: 10.1002/14651858.CD007679.pub3. PMID: 22258972

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...